Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Cardiology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
UTI Turns Out to Be Infective Endocarditis: An Unusual Presentation
9
Mins
May 2025
Infective endocarditis (IE) often presents in an unusual and vague manner, especially in its early stages, where symptoms can be…
Read more
9
Mins
23 May 2025
UTI Turns Out to Be Infective Endocarditis: An Unusual Presentation
Infective endocarditis (IE) often presents in an unusual and vague manner, especially in its early stages, where symptoms can be…
3
Mins
22 May 2025
Financial Toxicity: An Overlooked Driver of Heart Failure Risk in the USA
Heart failure is responsible not only for high morbidity and mortality, but also for significant out-of-pocket expenses for patients…
7
Mins
13 Mar 2025
Rare Anti-HMGCR-Induced Immune-Mediated Necrotising Myopathy
An acute necrotising myopathy is a distinct form of uncommon muscle disease characterised by the rapid advancement of weakness affecting…
10
Mins
18 Dec 2024
Reducing the CV Risks of Smoking
Smoking is a major risk factor for cardiovascular disease (CVD) and responsible for around 25% of all CVD-related deaths worldwide…
31 Oct 2024
Tackling Infectious Diseases
This interactive article summarises key discussions from GSK sponsored symposia that took place during the ESCMID Global Congress 2024, held from 27–30th April 2024 in Barcelona, Spain.
31 Oct 2024
Under the Lens: Progression of Diabetic Retinopathy and the Impact of Fenofibrate
With an increasing prevalence of diabetic retinopathy, a cause of vision impairment and blindness in those with diabetes, there is a need…
11
Mins
18 Oct 2024
Factor XI/XIa Inhibition: ESC Update
The emerging class of agents targeting factor XI/XIa offers the paradigm-shifting possibility of ‘haemostasis-sparing anticoagulation’…
11
Mins
10 Oct 2024
Advancing Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is an inherited disorder that may cause disabling and potentially life-threatening symptoms related to…
7
Mins
26 Sep 2024
Lifetime Management of Aortic Stenosis in Young Patients
The number of transcatheter aortic valve replacements/implantations (TAVR/TAVI) has nearly equalled that of the number of surgical aortic…
6
Mins
24 Sep 2024
Coarctation of Aorta Masquerading as a Spinal Arteriovenous Malformation
Coarctation of the aorta is a congenital disease involving the cardiovascular system. The presentation can range from being asymptomatic…
7
Mins
19 Sep 2024
Investigating Aortic Stenosis Among Haemodialysis Patients
Cardiovascular disease is still the leading cause of death in patients on haemodialysis (HD).1 Cardiac valve calcification (CVC)…
8
Mins
18 Sep 2024
Myocardial Crypts and Ventricular Fibrillation: Two Case Reports
Left ventricular myocardial crypts are rare structural abnormalities and are defined as invaginations traversing major than a half of the…
8
Mins
29 Aug 2024
Depressive Symptoms and Left Ventricular Diastolic Dysfunction in HIV
The prevalence of both major depressive disorder and cardiovascular disease (CVD) is higher among persons living with HIV (PWH)…
6
Mins
28 Aug 2024
Alleviation of Dyspareunia and Vaginal Dryness after Pelvic Artery Revascularisation
Vasculogenic female sexual dysfunction syndromes affect millions of ageing women worldwide, whose day-to-day symptoms of coital…
3
Mins
19 Aug 2024
Interview: Saraschandra Vallabhajosyula
Cardiogenic shock continues to carry a high mortality rate despite contemporary care, with no breakthrough therapies shown to improve…
11
Mins
13 Jun 2024
Congenital Heart Disease and Autism Spectrum Disorder
Children diagnosed with congenital heart disease (CHD) have an increased risk of developing neurodevelopmental disabilities…
15
Mins
13 Jun 2024
Endovascular Stenting for Superior Vena Cava Syndrome
Superior vena cava syndrome (SVCS) is a group of clinical manifestations, caused by an obstruction of venous blood flow to the heart…
4
Mins
18 Apr 2024
Interview: David L. Fischman
With over 20 years of experience as a cardiologist, what initially sparked your interest in the field, and continues to motivate you at…
9
Mins
25 Jan 2024
The AZALEA-TIMI 71 Study and the Future of Factor XI Inhibition: Reflections from the American Heart Association Scientific Congress 2023
Since its earliest days, the effective use of anticoagulation for prevention of stroke and other thromboembolic events has been limited by…
4
Mins
5 Oct 2023
The Impact of Guideline-Directed Medical Therapy Adherence on Cardiovascular Outcomes: A Critique of Recent Trials
This review scrutinises the role of guideline-directed medical therapy (GDMT) adherence in some studies and how it influenced…
4
Mins
5 Oct 2023
Editor’s Pick: Obstructive Sleep Apnoea as an Exacerbator of Vasospastic Angina
Little is known about the association between obstructive sleep apnoea (OSA) and vasospastic angina. The authors report the case of a…
8
Mins
5 Oct 2023
Characterisation of Patients with Acute Coronary Syndrome: A 10-Year Experience
Coronary intervention is a therapeutic method for acute coronary syndrome. Characterise patients with acute coronary syndrome treated…
12
Mins
5 Oct 2023
Risk Factors and Patterns of Myocardial Injury in Patients with COVID-19: A Single-Centre Cohort Study
The primary objective was to compare the risk factors and trends of patients with COVID-19 with and without biochemical evidence of…
9
Mins
5 Oct 2023
PCSK9 Targeting in the Management of Hypercholesterolaemia
In the current era of optimal risk factor modification, proprotein convertase subtilisin/kexin type 9 (PCSK9) targeting has emerged as a…
12
Mins
15 Aug 2023
Diagnosing Fabry Disease: Practical Clinical Recommendations and Guidance for Patients with Fabry Disease
This article was funded by Sanofi and is intended for healthcare professionals.
5
Mins
21 Apr 2023
Use of Echocardiography to Diagnose Obstructive Hypertrophic Cardiomyopathy
Fabian Knebel, Sana Klinikum, Berlin, Germany, and Department of Cardiology and Angiology, Charité Campus Mitte, Berlin, Germany, opened the podcast with a definition of hypertrophic cardiomyopathy (HCM), which is characterised by left ventricular hypertrophy. Knebel then described the symptoms of the condition, such as shortness of breath and syncope after physical exertion.
6
Mins
31 Mar 2023
Interview: Hannah Gower
Hannah Gower | Cardiology and Internal Medicine Speciality Registrar, Royal Cornwall Hospitals NHS Trust, UK
6
Mins
27 Mar 2023
Interview: Andrew R.J. Mitchell
Andrew R.J. Mitchell | Consultant Cardiologist at Jersey General Hospital, Saint Helier, Jersey; Honorary Consultant Cardiologist at Oxford University Hospitals NHS Foundation Trust, UK
9
Mins
16 Mar 2023
Heated Tobacco Products and Chronic Obstructive Pulmonary Disease: A Narrative Review of Peer-Reviewed Publications
An estimated 65 million people worldwide have moderate or severe chronic obstructive pulmonary disease (COPD), an umbrella term used to describe a group of progressive lung diseases that obstruct airflow such as emphysema and chronic bronchitis. Smoking contributes to an estimated 90% of COPD cases, as the harmful chemicals produced during tobacco combustion damage the lungs and airways. Although smoking cessation is the only intervention shown to improve COPD prognosis in smokers, many patients who try to quit continue to smoke.
5
Mins
17 Feb 2023
Hearts are NOT Made to Be Broken: Expert Opinion on Amyloid Light-Chain Cardiac Amyloidosis
Amyloid light-chain (AL) amyloidosis is a rare systemic disease caused by plasma cell dyscrasia. These plasma cells produce excess Ig light chains, which can misfold, aggregate, and deposit in tissues, resulting in toxicity and organ dysfunction. The heart is among the most commonly affected organs and cardiac involvement is associated with significantly worse outcomes.
4
Mins
6 Feb 2023
Mitral Annular Calcification Causing Retinal
Artery Occlusion
Caseous mitral annular calcification (CMAC), sometimes called liquefaction necrosis of mitral annular calcification (MAC), is a rare variant of MAC, a chronic degenerative process that progresses with age.
7
Mins
8 Dec 2022
Overview of Obstructive Hypertrophic Cardiomyopathy
Obstructive HCM is a condition in which the heart has thickened walls that are not caused by blockage of the heart valves or by very high blood pressure. For the majority of patients, the cause of their disease has a genetic basis and is hereditary. A genetic test can diagnose HCM in some patients, but the results are inconclusive in others.
9
Mins
8 Dec 2022
Current Evidence on Tobacco Harm Reduction in Pneumology: Interviews with Two Key Opinion Leaders
The harmful effects of cigarette smoke on human health are well documented and supported by evidence from preclinical, clinical, and epidemiological studies. Cigarette smoking damages multiple organs and leads to 8 million global deaths per year from direct use and passive exposure of cigarette smoke to non-smokers.
2
Mins
6 Dec 2022
Interview: Çetin Erol
We are honoured to share our EMJ Cardiology 2022 in review interview with Çetin Erol, Cardiologist at İbn-i Sina Hospital, Faculty of…
5
Mins
14 Oct 2022
Underdiagnosis and Poor Adherence Are Contributing to Rising Cases of Hypertension
Essential hypertension, a significant risk factor for cardiovascular diseases (CVD), kidney failure, and all-cause mortality, is largely reversible with lifestyle changes and highly efficacious medications. However, the prevalence of raised blood pressure (BP) is increasing globally. Considering its lack of symptoms, many people remain undiagnosed and unaware of the risks. In addition, a lack of perceived benefit makes adhering to pharmacological and non-pharmacological interventions challenging for patients.
5
Mins
6 Oct 2022
Effect of Age on the Abdominal Aortic Aneurysm: Fuzzy Logic Analysis
The aneurysm refers to the increase in arterial diameter in a localised position and this is characterised by the non-parallelism of the arterial wall. Despite prediction models trying to anticipate the onset of an aneurysm, the limits of their accuracy are often reached.
3
Mins
3 Oct 2022
Rare Association of Takotsubo Cardiomyopathy with Acquired Bartter-Like Phenotype and Colonic Stricture
Takotsubo syndrome (TTS), also known as stress-related cardiomyopathy or apical ballooning, is a transient systolic and diastolic dysfunction that is often preceded by some physical or emotional triggers. First described in Japan in 1990, it is derived from a Japanese word meaning ‘octopus pot’.
8
Mins
15 Sep 2022
Heated Tobacco Products and Cardiovascular Disease: A Narrative Review of Peer-Reviewed Publications
This article discussed cigarette smoking as a major risk factor for cardiovascular disease (CVD). Looking through the lens of toxic cigarette smoke constituents, the review described the oxidative stress and inflammatory responses induced following their entry into the bloodstream.
7
Mins
8 Sep 2022
Efficacy and Safety of Aficamten in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy
Highlighting a presentation that took place as part of the European Society of Cardiology’s (ESC) Heart Failure 2022 congress, this article summarised data on the efficacy and safety of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM).
4
Mins
26 Aug 2022
The Clock Is Ticking: The Imminent Need to Re-evaluate the Standard of Care in the 90-Day High-Risk Post-Acute Myocardial Infarction Period
The imminent need to re-evaluate the standard of care in the 90-day high-risk post-acute myocardial infarction period.
Loading posts...
« Previous
1
…
3
4
5
6
7
…
24
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View